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Considerable evidence links chronic obstructive
pulmonary disease (COPD) with systemic inflamma-
tion,1,2 including altered numbers3 and functions of
circulating inflammatory cells,4–6 cytokines,7,8 acute
phase proteins,3,7 and oxidative stress.9,10 This
indicates that COPD is not restricted to pulmonary
disease, but may also affect distant organs, e.g. by
inducing substantial skeletal muscle alterations11 and
weight loss.7 These factors may contribute to
exercise limitation12,13 and reduced quality of life in
these patients.14 Exercise may be beneficial for
patients with COPD, in part by improving exercise
tolerance (endurance and maximal exercise capa-
city), and training of muscles.15 On the other hand, it
is known that exercise, if sufficiently intense, leads to
a highly stereotyped immune response in healthy
subjects, mediated by an interplay of inflammatory
cells, hormones, cytokines, neural and hematological
factors,16 that can also affect distant organs.17 Also,
in subjects with cystic fibrosis it was found that low
intensity exercise could increase already elevated
circulating cytokines.18 Since COPD patients may
show signs of systemic inflammation, elevated levels
of circulating catecholamines, marked sympathetic
activation19,20 and muscle wasting21 at rest, it may be
expected that physical activity will further increase
these mediators. Indeed, recently it was shown that
moderate intensity exercise in COPD abnormally
increased plasma tumor necrosis factor-alpha (TNF-
a) levels.22 Moreover, exercise induces systemic23,24
and muscle25 oxidative stress in COPD patients. In
view of these data, we hypothesized that exercise
causes an exaggerated systemic inflammatory re-
sponse in COPD patients compared with healthy
subjects, which consequently might worsen the
effects on distant organs.
The purpose of this study was to characterize the
effects of a single bout of exhaustive exercise on
the systemic responses in COPD patients. There-
fore, levels of circulating catecholamines and
(subpopulations of) leukocytes as well as serum
levels of acute phase proteins (CRP) and the muscle
proteins creatine kinase (CK) and myoglobin (Mb)
were measured before and after maximal incre-
mental cycle ergometry.Methods
Subjects
Sixteen (10 males, 6 females) non-smoking COPD
patients (age 52–68 years) from our outpatientclinic participated in this study. These patients
had moderate to very severe COPD (FEV1 23–68%
predicted) according to global initiative for chronic
obstructive lung disease.26,27 They were free of
exacerbations for at least 2 months prior to the
study. Exclusion criteria were use of oral corticos-
teroids, long-term oxygen therapy, and other
exercise-limiting diseases. Inhaled corticosteroids
(ICS) (if used) were stopped 1 week prior to
exercise testing (ten patients). All patients used
inhaled bronchodilators (ipratropiumbromide and/
or b2-agonists), and none used theophylline. The
patients were recruited before going through a
rehabilitation program. For the control group,
eleven (9 males, 2 females) non-smoking, seden-
tary healthy subjects (age 47–64 years) were
recruited from the social environment of the
patient group. The study was conducted according
to the Declaration of Helsinki and approved by the
medical ethical committee of our hospital. Written
informed consent was obtained from all subjects.Pulmonary function
Standard pulmonary function tests including spiro-
metry, static lung volumes and diffusing capacity
for carbon monoxide (DLCO) were obtained prior to
cycle ergometry.Protocol cycle ergometry
All subjects performed a maximal, symptom lim-
ited, incremental exercise test. They cycled on an
electrically braked cycle ergometer (Masterlab,
Jaeger, Wu¨rzburg, Germany) at a pedaling rate of
60 rotationsmin1 breathing room air. The work-
load was increased every minute by 10% of
estimated maximum work capacity (Wmax) until
exhaustion. The maximum work capacity was
calculated according to the equitation of Jones et
al.28 This maximal value was then adapted to the
subject by multiplying it by FEV1/FEV1 predicted.
29
The exercise protocol resulted in a test duration of
8–12min, which meets the exercise testing recom-
mendations.30 Minute ventilation (V˙E), oxygen
consumption ð _VO2 Þ and carbon dioxide production
ð _VCO2 Þ were measured every 30 s breath-by-breath
(Oxyconbeta, Mijnhardt/Jaeger, Bunnik, The Neth-
erlands). Electrocardiography (ECG) was conducted
throughout the test and saturation was measured
using a pulse-oxymeter (Datex, Helsinki, Finland).
If ECG-changes or chest pain occurred, or satura-
tion fell below 85%, the test was stopped immedi-
ately. Blood pressure was measured every 2min
during the test.
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Exercise-induced systemic inflammatory response in COPD 1557Collection of blood samples
A cannula was inserted into the brachial artery
under local anesthesia to obtain arterial blood.
Arterial blood samples were collected at rest,
every 3min during exercise, at Wmax and 3, 30, 60
and 120min after the test. Two hours after the
exercise testing the arterial cannula was removed.
Venous blood was collected via a venapuncture at 6
and 24 h after the test for determination of muscle
damage markers (see below). Measurements after
exercise were corrected for plasma volume shifts
according to Dill and Costill.31
Analytical procedures
Blood for determination of hemoglobin, hemato-
crit, CRP (ELISA, detection limit 1 mgmL1) and
leukocytes was collected (at rest, Wmax, and 30, 60
and 120min after exercise) in vacutainers contain-
ing EDTA and analyzed immediately according to
standard laboratory assays.
To determine CK, Mb, uric acid, and glucose,
blood was collected in dry vacutainers and ana-
lyzed immediately in serum according to standard
laboratory assays.
For blood gas and lactate analysis, arterial blood
was collected in special heparinized syringes and
analyzed immediately (Gas analyzer Chiron 860).
Blood gasses ðPaO2; PaCO2Þ were measured pre-
exercise, every 3min during the exercise and 3min
after maximal work rate. Lactate levels were
determined enzymatically at rest and 3min after
maximal exercise.
Catecholamine measurement
Blood was collected at rest, directly after maximal
exercise and after 30min of recovery in pre-cooled
vacutainers containing heparin. Blood samples were
put on ice and spun down immediately. Supernatant
was stored in tubes containing 0.25mol L1 EGTA
and 0.2mol L1 glutathione in distilled water (pH
7.4). Epinephrine and norepinephrine were mea-
sured according to Willemsen et al.32
Phenotype analysis of peripheral blood
mononuclear cells (PBMC)
Blood samples for lymphocyte immunophenotyping
by three-color flow cytometry33 were collected at
rest, Wmax and 30, 60 and 120min after exercise in
heparinized vacutainers. Monoclonal antibodies
with a fluorescing label were used to identify the
numbers of helper/inducer T-lymphocytes (CD3+/CD4+), B-lymphocytes (CD19+) and natural killer
(NK) cells (CD3-/CD56+/CD16+).
Statistics
Differences in baseline values, anthropometric
variables and pulmonary function between healthy
subjects and patients with COPD were determined
with two-sample t-tests and Mann–Whitney U tests
(if the normality assumption (Kurtosis) was not
obtained). Repeated measures analysis of variance
(ANOVA) was used to analyze all responses to the
maximal exercise bout. Between-subject tests
were used to compare overall response differences
between the control and COPD group across the
time points (between-group effect). Single degree
of freedom orthogonal polynomials over time were
used to characterize possible changes caused by
exercise, i.e. linear and quadratic changes across
time (time effect). These polynomials were exam-
ined for absolute values with all time points and for
differences from baseline (for each subject). A
difference between the control and the COPD group
in the response pattern by exercise was tested
using the interaction between each polynomial and
the between subject factors (time*group effect).
Linear regression analysis was performed to test if
exercise capacity, catecholamine response, and
lymphocyte response were correlated.
Statistical significance was taken at the Po0:05
level. Results are presented as means7SE. Data
were analyzed with SPSS/PC+, version 12.0 (SPSS,
Chicago, IL).Results
Anthropometric and pulmonary function
data
Subjects’ characteristics and pulmonary function
data are provided in Table 1. Age and body mass
indices (BMI) were similar in both groups. The main
differences were observed in pulmonary function
where the COPD group showed moderate to very
severe airflow obstruction. There was no significant
difference in arterial oxygen or carbon dioxide
tension between the groups. None of the subjects
were hypoxemic at rest.
Catecholamines and systemic inflammation
at rest
As shown in Fig. 1, there was no significant
difference in plasma epinephrine levels at rest
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Table 1 Anthropometric and pulmonary function data in healthy subjects and patients with COPD.
Healthy subjects COPD patients
N 11 16
Male/female 9/2 10/6
Age, years 5672 6072
BMI, kgm2 27.571.3 25.371.2
FEV1, L 3.570.2 1.270.1***
FEV1, % pred 11074 4273***
FEV1/VC, % 7771 3972***
TLC, % pred 10874 11474
Dlco, % pred 10975 94711
PaO2, kPa 11.970.4 10.970.5
PaCO2, kPa 5.570.1 5.370.2
Data are expressed as means7SE.
Abbreviations: BMI, body mass index; FEV1, forced expiratory; volume in first second; VC, vital capacity; TLC, total lung
capacity; Dlco, diffusion capacity for carbon monoxide; PaO2, arterial oxygen tension PaCO2, arterial carbon dioxide tension;
pred, predicted value.
***Po0:001.
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Figure 1 Individual and mean values of baseline epinephrine, norepinephrine, circulating leukocytes, neutrophils,
monocytes, and CRP in healthy subjects and patients with COPD. *Po0:05, ***Po0:001.
H.A.C. van Helvoort et al.1558between COPD patients and healthy subjects.
Baseline norepinephrine levels, however, were
significant higher (Po0:05) in COPD patients.
Systemic inflammation at rest was indicated by
increased numbers of total circulating leukocytes
(Po0:05), neutrophils (Po0:05), and monocytes
(Po0:05) as well as enhanced CRP levels (Po0:001)
in COPD patients. No significant differences be-
tween COPD patients and healthy subjects were
measured in numbers of circulating lymphocytes
and the subsets NK-cells, T- and B-lymphocytes.Maximal exercise test
Physiological data
Physiological responses to exercise are shown in
Table 2. As expected, Wmax was significantly lower
in COPD patients (Po0:001). Also, duration of the
exercise test, maximal oxygen uptake ðpeak _VO2 Þ
and minute ventilation (peak V˙E) were significantly
lower in the COPD group. The peak V˙E, however,
represented 9676% of the maximal voluntary
ventilation (MVV) in COPD patients and 6874% inthe control group (Po0:01). PaO2 significantly
decreased during exercise in COPD patients
(Po0:05), while PaCO2 increased (Po0:001). Six
patients became hypoxemic and five became
hypercapnic during exercise. No changes in PaO2
occurred in healthy subjects, while PaCO2 de-
creased at maximal exercise (Po0:01). In both
groups, a significant increase (Po0:01) in plasma
lactate was observed at Wmax. This increase of
lactate levels was significantly lower in COPD
patients compared with healthy subjects (D lac-
tate; 4.170.7mM vs. 7.370.9mM, Po0:05).
Catecholamines
Plasma levels of epinephrine and norepinephrine
before and after the exercise test are shown in Fig.
2. Exercise led to significant changes in plasma
epinephrine and norepinephrine in both groups
(Po0:001 for both catecholamines). The response
to exercise was significantly lower in COPD patients
compared with healthy subjects for both catecho-
lamines (Po0:05 for epinephrine, and Po0:001 for
norepinephrine). The plots in Fig. 3 show that the
lower response of catecholamines to exercise in
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Table 2 Physiological data after maximal exercise in healthy subjects and patients with COPD.
Healthy subjects COPD patients
Wmax, W 201718 90711***
Wmax, % pred 7976 5775**
Endurance, s 729733 519732***
Max HR, beatsmin1 16373 12875***
Max HR, % pred 9972 8073***
Peak _VO2 , Lmin
1 2.470.18 1.370.12***
Peak _VO2 30.572.7 17.471.2***
Peak _VO2 10878 6575***
Peak V˙E, Lmin
1 8476 4374***
Peak V˙E, % MVV 6874 9676**
PaO2, kPa 12.570.5 9.770.4***
PaCO2, kPa 4.970.1 6.070.2***
Lactate, mM 8.971.0 5.270.7**
Data are expressed as means7SE.
Abbreviations: Wmax, maximal work capacity; endurance, duration of exercise test; HR, heart rate; peak V˙O2, maximal oxygen
consumption; V˙E, minute ventilation; MVV, maximal voluntary ventilation; PaO2, arterial oxygen tension; PaCO2, arterial carbon
dioxide tension; pred, predicted.
**Po0:01, ***Po0:001.
Exercise-induced systemic inflammatory response in COPD 1559COPD patients were related the relative lower work
intensities they performed. Also, within the COPD
group, Wmax and peak _VO2 were positively corre-
lated with changes in norepinephrine (r ¼ 0:60,
Po0:05 and r ¼ 0:57, Po0:05; respectively). As
described above, basal levels of norepinephrine
were significantly higher in COPD patients com-
pared with healthy subjects (Po0:01). To exclude
influence of inhaled b2-agonists on catecholamine
levels, a subgroup of six COPD patients was asked to
stop the inhalation of b2-agonists for one week and
to perform a second maximal exercise test after
this period. Discontinuation of inhaled b2-agonists
in these patients for one week did not affect
maximal exercise capacity nor levels of catechola-
mines at rest (epinephrine, P ¼ 0:64; norepinephr-
ine, P ¼ 0:73), or at Wmax (epinephrine, P ¼ 1:0;
norepinephrine, P ¼ 0:74), see Table 3.
Systemic inflammation
Numbers of total circulating leukocytes in both
COPD patients and healthy subjects at rest, directly
after exercise and during recovery are shown in Fig.
4A. Maximal exercise caused an immediate increase
of circulating leukocytes in both COPD patients
(from 7.670.7 to 9.270.9* 109 cells L1) and
healthy subjects (from 5.470.2 to 7.470.2 109
cells L1), followed by a rapid decrease during the
first 30min of recovery and a second increase later
in the recovery period (time effect: Po0:001). The
mean numbers of leukocytes were significant higher
in COPD patients compared with healthy subjects(Po0:05), but the response to exercise was
comparable in both groups (time*group effect:
P40:05).
The exercise-induced response of leukocytes as
caused by its subsets, is also shown in Fig. 4. In all
subsets, a significant response to exercise was
measured in both COPD patients and healthy
subjects (Po0:001). The mean numbers of both
neutrophils (Fig. 4B) and monocytes (Fig. 4C)
before and after exercise were significantly higher
in COPD patients compared with healthy subjects
(Po0:05 and Po0:01, respectively), but the re-
sponses (absolute and relative) to exercise were
not different. As shown in the last panel of Fig. 4
(4D), the absolute response of lymphocytes caused
by exercise was significant lower in COPD patients
compared with healthy subjects (Po0:001). In
addition to this finding, significant correlations
(Po0:001) were found between exercise capacity,
catecholamine response, and lymphocyte response
(Fig. 5). In addition, within the COPD group, peak
_VO2 was correlated with changes in lymphocytes
(r ¼ 0:57, Po0:05), and changes in norepinephrine
were related to the lymphocyte response (r ¼ 0:54,
Po0:05). Evaluation of the exercise-induced re-
sponse of the NK-cells and lymphocyte subsets
resulted in similar responses for COPD patients and
healthy subjects. NK-cells (Fig. 6A) and B-lympho-
cytes (Fig. 6B) resembled the response of the total
lymphocytes, although the reduction in the re-
sponses of COPD patients was not significant here.
The response of T-lymphocytes immediately after
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Figure 2 Effects of exercise on plasma concentrations
epinephrine (A) and norepinephrine (B) in both healthy
subjects and patients with COPD. Exercise induced a
significant response of the catecholamines in both groups
(Po0:001). Both epinephrine and norepinephrine re-
sponses were lower in COPD patients (Po0:05).
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Figure 3 Exercise-induced changes in norepinephrine
levels related to maximal workload (A) and peak _VO2 (B)
in healthy subjects and patients with COPD.
H.A.C. van Helvoort et al.1560maximal exercise was the same in both groups
(Fig 6C). The difference occurred after two
hours recovery when the T-lymphocytes of COPD
patients were still elevated from baseline levels
(Po0:01).
Discontinuation of b2-agonists in a subset of COPD
patients did not affect numbers of (subsets of)
leukocytes at rest (P ¼ 0:3), or after maximal
exercise (P ¼ 0:8), see Table 3.
Plasma levels of CRP after exercise did not differ
from rest values in both COPD patients and healthy
subjects.Muscle damage markers
As shown in Table 4, serum levels of the muscle
damage markers CK and Mb did not differ between
COPD patients and healthy subjects at rest
(P ¼ 0:4) and did not change significantly in
response to short exhaustive bicycle exercise.Discussion
The present study shows that the exercise-induced
systemic inflammatory response is not exaggerated
in COPD patients compared with healthy subjects.
The systemic inflammatory response to exhaustive
exercise at relatively low external workload in
COPD patients is comparable with the response to
high intensity maximal exercise in healthy subjects,
but occurs at a higher level in COPD. Therefore, the
absolute number of circulating inflammatory cells
is intensified to higher levels in patients with COPD,
which may stimulate several inflammatory media-
tors and processes. Owing to lower exercise
intensity, catecholamine response was lower in
COPD patients. These data indicate that patients
with COPD performing strenuous exercise are
exposed to an intensified systemic inflammation.Catecholamines
In response to exercise above 60% of peak _VO2,
plasma concentrations of a number of stress
ARTICLE IN PRESS
Table 3 The effect of discontinuation of inhaled b2-agonists on exercise capacity, catecholamines and
circulating leukocytes.
With b2-agonists (n ¼ 6) Without b2-agonists (n ¼ 6)
At rest At Wmax At rest At Wmax
Wmax, W 114713 112714
Peak _VO2 % pred 8176 8078
Epinephrine, nmol L1 0.3970.1 2.171.0 0.3170.1 2.171.0
Norepinephrine, nmol L1 2.570.5 15.672.2 2.270.4 17.173.9
Total leukocytes, *109 L1 5.470.5 7.370.8 6.171.0 7.671.1
Data are expressed as means 7SE.
Abbreviations: Wmax, maximal work capacity; peak V˙O2, maximal oxygen consumption.
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Figure 4 Effects of exercise on circulating leukocytes and subsets in both healthy subjects and patients with COPD.
Exercise caused significant responses of total leukocytes (A), neutrophils (B), monocytes (C), and lymphocytes (D) in
both groups. Responses of leukocytes and the subsets neutrophils and monocytes were similar in patients and healthy
subjects. Lymphocyte response was significantly lower in COPD patients (Po0:001).
Exercise-induced systemic inflammatory response in COPD 1561hormones, including epinephrine and norepinephr-
ine, increase and return to prevalues shortly after
exercise.34 Discharge from sympathic splanchnic
nerves and innervation of the adrenal medulla
result in the release of epinephrine and norepi-
nephrine into the plasma immediately after start of
intense muscular exercise. These stress hormones
have marked physiological effects on heart rate andvasomotor tone, and ultimately on blood flow
through lymphoid tissues and leukocyte circulation
patterns.35 In the present study, plasma catechola-
mine levels indeed increased during maximal
exercise in both COPD patients and healthy controls
and declined rapidly after exercise. Catechola-
mines increase almost linearly with the duration of
exercise and exponentially with intensity, when it is
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Figure 5 The influence of exercise capacity (A) and
subsequent changes in norepinephrine (B) on lymphocyte
response to exercise.
H.A.C. van Helvoort et al.1562expressed relative to individual’s peak _VO2.
36 The
lower catecholamine levels of COPD patients at
maximal exercise compared with healthy controls
in this study can at least partially be explained by
the lower exercise capacity (both ventilatory
capacity and maximum workload) of the patients
or by the shorter duration of their exercise, as is
illustrated when exercise capacity is plotted
against changes of noradrenaline (Fig. 3). Debigare
and coworkers37 showed that a greater increase in
the cycling load during an incremental exercise test
resulted in higher achieved peak loads. According
to them, peak _VO2, however, was independent of
the increase in workload. Because the catechola-
mine response was not only correlated with Wmax in
the present study, but also with peak _VO2, we think
that our results were not influenced by the
different exercise protocols. Furthermore, the
study was not designed to compare the increases
of catecholamine levels between the groups at
isotime or isoworkload exercise between COPD
patients and healthy subjects. If the increases in
cycling load had been similar in patients andhealthy subjects, probably the exercise recommen-
dations of 8–12min test duration30 were not met.
Based on our results at maximal exercise, it is
suggested that the catecholamine response to
exhaustive exercise is not affected by COPD. These
results are in disagreement with data of Colice et
al.,38 who reported that the rate of increase of
epinephrine (but not norepinephrine) with maximal
exercise was smaller in hypoxic COPD patients than
in healthy controls. Their findings supported the
concept that (chronic) hypoxia interferes with the
adrenal medullary response to exercise. In our
study, most of the COPD patients remained nor-
moxic during exercise, which may explain the
difference between these studies.
Remarkably, plasma levels of norepinephrine at
rest were higher in COPD patients compared with
healthy subjects in our study. Other investigators
also found elevated baseline values of (nor-)
epinephrine in (a subgroup of) COPD patients.38,39
The precise mechanism of these findings is unclear.
Beta2-adrenoreceptor agonists, used by many COPD
patients, produce a number of metabolic
changes.40 In a study of Malerba et al.,41 plasma
norepinephrine concentrations of COPD patients
using systemic b2-agonists were significantly in-
creased at rest and especially during cardiopul-
monary exercise test, due to activation of the
orthosympathetic nervous system and anaerobic
metabolism. This possible b2-effect was ruled out in
our study because a subgroup of patients per-
formed a second test after discontinuation of their
use of inhaled b2-agonists for one week. Disconti-
nuation of these b2-agonist caused no differences in
catecholamine levels at rest or after exercise
testing.Systemic inflammation
The earliest and most consistent observation of the
exercise-immune interaction has been the so-
called
’ ’
leukocytosis of exercise’’.42 Despite varia-
tion in type, intensity, duration of the exercise, and
fitness level of the subjects, several consistent
patterns emerge regarding the leukocyte subpopu-
lations in blood. The leukocytosis in both COPD
patients and healthy controls in the present study
reflected the previously described patterns: an
early leukocytosis characterized mainly by an
increase in all subsets, followed by a second phase
during which neutrophils gradually increased and
lymphocytes concentrations rapidly fell down. This
typical inflammatory response of total leukocytes
and the subsets neutrophils and monocytes had a
similar pattern in COPD patients and healthy
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Figure 6 Effects of exercise on circulating NK cells and lymphocyte subsets in both healthy subjects and patients with
COPD. The responses of NK-cells (A) and B-lymphocytes (B) to exercise was comparable in both groups, while the
pattern of the response of the T-lymphocytes (C) differed between the groups after 2 h of recovery (Po0:01).
Table 4 Muscle damage markers before and after exercise in healthy subjects and COPD patients.
At rest Wmax Wmax+1h Wmax+2h Wmax+6h Wmax+24h
CK (U L1)
Healthy subjects 127715 122715 127716 127717 127714 126715
COPD patients 106713 106713 98712 100712 104712 100712
Mb (mg L1)
Healthy subjects 3074 3375 3375 3174 3474 3374
COPD patients 3076 3176 3175 3275 3476 3375
Data are expressed as means7SE.
Abbreviations: CK, creatine kinase; Mb, myoglobin.No significant differences between the groups or in response to exercise
were observed.
Exercise-induced systemic inflammatory response in COPD 1563subjects, but occurred on an elevated level in the
patients. Acute lymphocytosis also occurred follow-
ing maximal exercise in all subjects, but the
increase in lymphocytes, especially B-lymphocytes,
and NK-cells was impaired in COPD patients (only
significance in total lymphocytes). Absence of
significant differences in B-lymphocytes and NK-
cells can partly be attributed to relative large
interindividual variability that is known in thesecells,43 which results in large standard errors seen
in the present study. According to different
models,35,42,44 catecholamines are responsible for
the acute exercise-effects of lymphocyte subpopu-
lations and NK-cells. Finding less increase in levels
of catecholamines in COPD patients (due to relative
low intensity exercise) supports our results of a
slightly decreased lymphocytosis in these patients
(Fig. 5). T-lymphocyte response of COPD to exercise
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H.A.C. van Helvoort et al.1564resembled the response of controls, except for the
remained elevation of T-lymphocytes of COPD
patients after 2 h.
With stopping the use of ICS, if used, one week
prior to the study, possible declining effects of ICS
on systemic inflammatory markers45,46 were pre-
vented. Again, any possible effect of b2-agonists
47
on different leukocyte counts can be ruled out
because patients, who stopped the inhalation of
these agonists, did not show any difference in
leukocyte baseline levels or levels after the
maximal exercise test.
Although COPD patients had increased basal
levels of CRP compared with healthy subjects,
exercise did not change the levels in both groups.
Serum levels of acute phase reactants do change
with inflammation,48 but with respect to exercise
models, the serum levels of these reactants have
not been well characterized. To our knowledge, no
data are reported about CRP levels after exercise in
COPD patients. While Pyne et al.,49 published no
changes in CRP after 40min uphill (90% of peak _VO2)
or downhill (52% of peak _VO2) running in healthy
subjects, Mastaloudis et al.,50 recently demon-
strated remarkable increases in CRP in ultra
marathon runners (423min, 71% of peak _VO2).
Additional research on the impact of exercise on
acute phase reactants is needed.Limitations
In the present study, the gender distribution is
different between the two study groups. Although
there is no consensus in the literature, some data51
suggest that there may be gender-based differ-
ences in muscle damage, inflammation and oxida-
tive stress after exercise, possibly caused by
estrogen. Because all females included in the
presented study were postmenopausal, the possible
effect of estrogen can be minimized. In addition,
Moyna et al.,52 showed that the alterations in the
numbers of circulating leukocytes during and
following an acute progressive incremental exer-
cise test (3 periods of 6min cycling at 55%, 70%, and
85% of peak _VO2) are independent of gender.
Therefore, the exercise-induced inflammatory re-
sponses found in this study are probably not
affected by gender differences.Leukocyte source
The source of the leukocytes mobilized during
exercise and what mechanisms are involved in the
mobilization were not subject of this study but are
of considerable interest. It is clear that theimmediate mobilized cells are derived from the
marginated or non-circulating leukocyte pool(s),
while the delayed (second) increase of leukocytes
after two hours (especially neutrophils) can also be
influenced by release of (immature) cells from the
bone marrow. Less clear is the place in the body
where the pool for the immediate response is
located. The spleen, the lungs, and the peripheral
blood vessels seem important candidates.16,42
Whether the source(s) of exercise-induced leuko-
cytosis or the mechanism(s) involved in this
mobilization differs between healthy subjects and
COPD patients, is not known yet. Speculatively, the
lungs might play a more important role in the
leukocytosis of COPD patients compared to healthy
subjects because pulmonary inflammation causes
increased levels of neutrophils and lymphocytes in
the lungs.Markers of muscle damage
Muscular exercise commonly results in injury to
fibers in the active muscles, particularly when the
exercise is relatively intense (460% of peak _VO2),
of long duration (430min) and/or includes ec-
centric contractions.11,53 One of the clinical symp-
toms associated with muscle injury includes
elevated plasma levels of muscle proteins (e.g.
CK and Mb). In the presented study, no evidence of
muscle damage was found systemically in COPD
patients or in healthy subjects after a short bout of
maximal exercise. Both groups did not show
changes in circulating levels of CK and Mb after
exercise. The mechanism of metabolic stress,
characterized by disturbances in cellular metabo-
lism, has been proposed to explain muscle damage
after prolonged (430min) high intensity or ex-
haustive exercise.11 Metabolic stress not only
induces muscle damage, but also activates the
hormonal and inflammatory response to repair
tissue damage. Several explanations for not finding
evidence of muscle damage are possible. Firstly,
changes in plasma levels of muscle proteins are
related to membrane (sarcolemmal) damage or
permeabilization. Absence of changes in these
proteins does not exclude injury of sarcomere or
other organelles (e.g. mitochondria). Using muscle
proteins in blood as marker for muscle damage has
been criticized by many authors.54 Some of them
even conclude that muscle damage can never be
correctly estimated by any marker in circulating
blood because these markers are always a reflec-
tion of the difference between release and uptake
by other tissues.55 Secondly, we did not assess
muscle injury or damage directly. And finally, the
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patients could have been too short to induce
markedly muscle damage. For these reasons,
definite conclusions about muscle damage cannot
arise from the present findings.Clinical relevance
Mechanisms and consequences of systemic inflam-
mation are still poorly understood. So far, it is
thought that systemic inflammation may be asso-
ciated with nutritional abnormalities, weight loss,
skeletal muscle dysfunction and subsequently ex-
ercise tolerance in patients with COPD.1 Increased
numbers of leukocytes and also pre-activation of
these cells, especially monocytes and neutrophils,
have been reported in earlier studies with stable
COPD patients.2 Changes in the numbers and
functions of these cells may be of relevance for
the normal process of neutrophils clearance by
macrophages from inflamed tissues.4,56,57 High
levels of circulating leukocytes will also affect
production of inflammatory mediators and reactive
oxygen species, which together play an important
role in the regulation of systemic inflammatory
response and the possible effects on distant organs.
Circulating lymphocytes have been less well stu-
died than circulating neutrophils in patients with
COPD. There are some indications of abnormal
lymphocyte function in these patients,58 but
whether these issues influence patient’s defense
against inflammation, remains to be resolved.
Although the present study shows that the
exercise-induced leukocytosis in COPD patients is
not different from healthy subjects, two important
aspects have to be kept in mind. Firstly, the
patterns of the leukocytosis are not different
between the groups, but the absolute numbers of
the inflammatory cells in COPD patients rise to
rather high levels. These levels probably also affect
other parts of the inflammatory cascade, which
together contribute to a further increase of
systemic inflammation. A second concern is the
comparison of exercise tests of healthy subjects
and ventilatory limited patients. Unlike healthy
subjects, patients with COPD become exhausted at
low external workload; for instance during daily life
activities, which therefore may result in a more
frequent exposure to systemic inflammation. Dur-
ing daily life activities, patients with COPD reach a
_VO2 of 8–10mL kg
1min1.59,60 In the present
study, however, a standardized maximal exercise
protocol was used, resulting in a mean peak _VO2 of
17mL kg1min1 in the COPD patients. Therefore,
further studies are needed to investigate ifsubmaximal exercises and daily life activities also
leads to an increase of systemic inflammation as
shown in the present study.
In summary, the present study shows that
exercise-induced systemic inflammatory response
is not exaggerated in COPD compared with healthy
subjects, but occurs on higher levels in COPD.
Unlike healthy subjects, COPD patients become
easily exhausted during daily life by using a relative
high percentage of their Wmax and peak _VO2.
Recurrent exhaustion and fatigue may therefore
result in frequent exposure to intensified levels of
systemic inflammation that may also affect several
distant organs. In these patients, an association
exists between systemic inflammation, metabolic
derangement,61 oxidative stress and skeletal mus-
cle dysfunction.1 These processes further enhance
the extrapulmonary effects of COPD by positive
feedback mechanisms and autocrine functions and,
thus, may maintain the vicious cycle of COPD,
systemic effects and inactivity. Future investiga-
tions are needed to further clarify the exercise-
induced inflammatory response in COPD patients
and its (systemic and local) clinical consequences in
view of treatment of these patients.Acknowledgements
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